Coherus Oncology (CHRS) Non-Current Assets (2013 - 2026)
Coherus Oncology (CHRS) reported Non-Current Assets of $57.4 million for Q2 2026, down 3.1% from $59.26 million a year earlier and down 4.3% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology posted Non-Current Assets of $51.64 million, down 51.7% from FY2024.
- Non-Current Assets has a five-year compound annual growth rate of -7.0% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $106.95 million in FY2024 (-30.5%), $153.97 million in FY2023 (+54.6%), $99.61 million in FY2022 (+29.3%) and $77.01 million in FY2021 (+3.8%).
- Five-year quarterly Non-Current Assets spans a low of $51.64 million in Q4 2025 and a high of $153.97 million in Q4 2023.
- Year over year, Non-Current Assets has now declined in each of the last eight quarters, with an average decline of 31.6% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q1 2024 (growth of 57.3%); the low point was Q3 2025 (a decline of 59.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $59.99 million (Q1 2026), $51.64 million (Q4 2025) and $55.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 57.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.40 Mn |
| Mar 31, 2026 | 59.99 Mn |
| Dec 31, 2025 | 51.64 Mn |
| Sep 30, 2025 | 55.56 Mn |
| Jun 30, 2025 | 59.26 Mn |
| Mar 31, 2025 | 60.89 Mn |
| Dec 31, 2024 | 106.95 Mn |
| Sep 30, 2024 | 135.98 Mn |
| Jun 30, 2024 | 116.92 Mn |
| Mar 31, 2024 | 136.07 Mn |
| Dec 31, 2023 | 153.97 Mn |
| Sep 30, 2023 | 139.42 Mn |
| Jun 30, 2023 | 84.11 Mn |
| Mar 31, 2023 | 86.50 Mn |
| Dec 31, 2022 | 99.61 Mn |
| Sep 30, 2022 | 102.63 Mn |
| Jun 30, 2022 | 99.22 Mn |
| Mar 31, 2022 | 80.94 Mn |
| Dec 31, 2021 | 77.01 Mn |
| Sep 30, 2021 | 68.69 Mn |
API Access
Coherus Oncology Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();